The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors.

"ccss data are publicly available on dbgap at https://www ncbi nlm nih gov/gap/ through its accession number phs001327 v2 p1 and on the st jude survivorship portal within the st."

"Declarations Ethics approval and consent to participateThe protocol for the study has been reviewed and approved by the University of Chicago Institutional Review Board (CIRB21-0176), St. Jude Children’s Research Hospital Institutional Review Board (IRB21-0803), and the University of Pennsylvania Institutional Review Board (IRB-848501). The University of Pennsylvania is the IRB of record. Participants electronically sign an informed consent form that is available on the CCSS Long-Term Follow Up study website. Project PIs, research staff, and staff at the CCSS Coordinating Center are available to participants for questions and concerns. All methods were carried out in accordance with relevant guidelines and regulations. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work is supported through the National Cancer Institute [National Cancer Institute (R01CA237369, MPI: Henderson, Bradbury)], and (CA55727, G.T. Armstrong, Principal Investigator). Support to St. Jude Children’s Research Hospital also provided by the Cancer Center Support (CORE) grant (CA21765, C. Roberts, Principal Investigator) and the American Lebanese-Syrian Associated Charities (ALSAC)."

"Trial registration This protocol was registered at clinicaltrials.gov (NCT04455698) on July 2, 2020."